STAT+: Patient groups balk at former AstraZeneca official negotiating U.K.-India free trade deal
More than 200 civil society and patient advocacy groups are urging the U.K. government to…
Category: patents
Opinion: Clearing the patent thicket: A pathway to faster generic drug approvals
Revelations that AbbVie, the manufacturer of Humira, made more than $100 billion in extra profits…
.jpg)
STAT+: U.S. delays backing for patent waivers on Covid-19 therapies and diagnostics
The U.S. government will not support extending a Dec. 17 deadline for waiving intellectual property…
STAT+: European Commission says preliminary findings indicate Teva violated antitrust rules
After three years of probing, the European Commission has reached a preliminary decision that Teva…
STAT+: Solicitor general recommends Supreme Court shouldn’t review an Amgen patent case
In a setback to Amgen, the U.S. solicitor general recommended that the Supreme Court not…
STAT+: Federal patent initiatives could cause ‘headwinds’ for drugmakers and their broad filings
For the second time this month, the U.S. Patent & Trademark Office has taken a…
STAT+: ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when
In response to criticism, ViiV Healthcare has agreed to license its long-acting injectable HIV prevention…
STAT+: Alnylam sues Pfizer and Moderna for patent infringement in development of Covid-19 vaccines
Alnylam Pharmaceuticals has filed separate lawsuits alleging that Pfizer and Moderna infringed its patents in…
STAT+: A battle is brewing between a senator and a nonprofit over pharma patenting practices
As the pharmaceutical industry faces pointed criticism over its patent practices, an effort appears to…
STAT+: Moderna looks to enforce its Covid-19 vaccine patents in wealthy countries
Amid intense public pressure, Moderna (MRNA) updated a pledge not to enforce patents for its…
STAT+: Oxfam wants the SEC to investigate Moderna for ‘misleading’ investors about its Covid patent dispute with NIH
Oxfam America has filed a complaint with securities regulators accusing Moderna (MRNA) of providing “misleading…
STAT+: AbbVie asks the U.S. International Trade Commission to investigate Alvotech’s plans for a biosimilar Humira
In its latest bid to defend its franchise product, AbbVie (ABBV) has filed a complaint…
STAT+: Facing intense criticism, Moderna pauses bitter dispute with the NIH over Covid-19 vaccine patents
Moderna (MRNA) has halted a rancorous patent dispute with the U.S. government over assigning credit…
Opinion: Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing
The Senate began its confirmation hearing last week for President Biden’s nominee to head the…
Opinion: STAT+: Why does the FDA want to stop improving medicines via patent ‘areas of concern’?
It’s hardly unprecedented for one federal agency to encroach on another’s turf. But the latest intra-executive-branch…
.jpg)
STAT+: U.S. lawmakers accuse patent office of weakening patent challenges and allowing drug prices to rise
A bipartisan group of lawmakers has accused the U.S. Patent & Trademark Office of “weakening”…
STAT+: Advocates urge Biden to name patent office director that could transform drug pricing
As the White House readies to name a new head of the U.S. Patent &…